09:59 AM EDT, 03/11/2025 (MT Newswires) -- Kane Biotech ( KNBIF ) on Tuesday rose 5.6% after the company signed a three-year distribution agreement with Best Buy Medical Canada for its antimicrobial wound gel product line.

"This partnership with Best Buy Medical allows us to improve access to innovative wound care solutions for Canadians suffering from chronic, non-healing wounds," said Kane Biotech ( KNBIF ) Chief Executive Marc Edwards. "By expanding our distribution network, ... we are also tapping into a significant financial opportunity in the Canadian wound care market."

Shares of the company were last up $0.005 at $0.095 on the TSX Venture Exchange.

Price: 0.10, Change: +0.01, Percent Change: +5.56